The company said sales for June 30, 2024 over the 3 months rose 0.2% to $2.081 billion, and organic sales grew 1.3%. GAAP EPS was $0.51, and adjusted EPS was $1.56.

1. 01

   The company said sales for June 30, 2024 over the 3 months rose 0.2% to $2.081 billion, and organic sales grew 1.3%. GAAP EPS was $0.51, and adjusted EPS was $1.56.

2. 02

   Solventum said operating income for Q2 was $244 million on a GAAP basis (operating margin of 11.7%) and $430 million on a non-GAAP basis (20.7%). The company cited lower gross margins and higher operating expenses tied to public company and standalone functional build-out as reasons for the lower operating margin.

3. 03

   Solventum said net cash provided by operating activities for Q2 (3 months) was $355 million, and free cash flow was $297 million. Free cash flow is operating cash flow less purchases of property, plant and equipment of $58 million.

4. 04

   The company said it raised its full-year organic sales growth outlook to 0% to +1.0% (previously -2% to 0%) and its adjusted EPS outlook to $6.30 to $6.50 (previously $6.10 to $6.40). Its free cash flow outlook is unchanged at $700M to $800M.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.